Global Chagas Disease Drug Market Insights and Forecast to 2031

Report ID: 1563967 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Chagas Disease Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Chagas Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Cz-007
        1.2.3 Cz-008
        1.2.4 D-121
        1.2.5 DNDI-0690
        1.2.6 EPLBS-1246
        1.2.7 EPLBS-967
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Chagas Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Chagas Disease Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Chagas Disease Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Chagas Disease Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Chagas Disease Drug Sales by Region
        2.4.1 Global Chagas Disease Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Chagas Disease Drug by Region (2023-2028)
    2.5 Global Chagas Disease Drug Revenue by Region
        2.5.1 Global Chagas Disease Drug Revenue by Region (2017-2022)
        2.5.2 Global Chagas Disease Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Chagas Disease Drug Sales by Manufacturers
        3.1.1 Global Top Chagas Disease Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Chagas Disease Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chagas Disease Drug in 2021
    3.2 Global Chagas Disease Drug Revenue by Manufacturers
        3.2.1 Global Chagas Disease Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Chagas Disease Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Chagas Disease Drug Revenue in 2021
    3.3 Global Chagas Disease Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Chagas Disease Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Chagas Disease Drug Sales by Type
        4.1.1 Global Chagas Disease Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Chagas Disease Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Chagas Disease Drug Sales Market Share by Type (2017-2028)
    4.2 Global Chagas Disease Drug Revenue by Type
        4.2.1 Global Chagas Disease Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Chagas Disease Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Chagas Disease Drug Price by Type
        4.3.1 Global Chagas Disease Drug Price by Type (2017-2022)
        4.3.2 Global Chagas Disease Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Chagas Disease Drug Sales by Application
        5.1.1 Global Chagas Disease Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Chagas Disease Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Chagas Disease Drug Sales Market Share by Application (2017-2028)
    5.2 Global Chagas Disease Drug Revenue by Application
        5.2.1 Global Chagas Disease Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Chagas Disease Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Chagas Disease Drug Price by Application
        5.3.1 Global Chagas Disease Drug Price by Application (2017-2022)
        5.3.2 Global Chagas Disease Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Chagas Disease Drug Market Size by Type
        6.1.1 North America Chagas Disease Drug Sales by Type (2017-2028)
        6.1.2 North America Chagas Disease Drug Revenue by Type (2017-2028)
    6.2 North America Chagas Disease Drug Market Size by Application
        6.2.1 North America Chagas Disease Drug Sales by Application (2017-2028)
        6.2.2 North America Chagas Disease Drug Revenue by Application (2017-2028)
    6.3 North America Chagas Disease Drug Market Size by Country
        6.3.1 North America Chagas Disease Drug Sales by Country (2017-2028)
        6.3.2 North America Chagas Disease Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Chagas Disease Drug Market Size by Type
        7.1.1 Europe Chagas Disease Drug Sales by Type (2017-2028)
        7.1.2 Europe Chagas Disease Drug Revenue by Type (2017-2028)
    7.2 Europe Chagas Disease Drug Market Size by Application
        7.2.1 Europe Chagas Disease Drug Sales by Application (2017-2028)
        7.2.2 Europe Chagas Disease Drug Revenue by Application (2017-2028)
    7.3 Europe Chagas Disease Drug Market Size by Country
        7.3.1 Europe Chagas Disease Drug Sales by Country (2017-2028)
        7.3.2 Europe Chagas Disease Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Chagas Disease Drug Market Size by Type
        8.1.1 Asia Pacific Chagas Disease Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Chagas Disease Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Chagas Disease Drug Market Size by Application
        8.2.1 Asia Pacific Chagas Disease Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Chagas Disease Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Chagas Disease Drug Market Size by Region
        8.3.1 Asia Pacific Chagas Disease Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Chagas Disease Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Chagas Disease Drug Market Size by Type
        9.1.1 Latin America Chagas Disease Drug Sales by Type (2017-2028)
        9.1.2 Latin America Chagas Disease Drug Revenue by Type (2017-2028)
    9.2 Latin America Chagas Disease Drug Market Size by Application
        9.2.1 Latin America Chagas Disease Drug Sales by Application (2017-2028)
        9.2.2 Latin America Chagas Disease Drug Revenue by Application (2017-2028)
    9.3 Latin America Chagas Disease Drug Market Size by Country
        9.3.1 Latin America Chagas Disease Drug Sales by Country (2017-2028)
        9.3.2 Latin America Chagas Disease Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Chagas Disease Drug Market Size by Type
        10.1.1 Middle East and Africa Chagas Disease Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Chagas Disease Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Chagas Disease Drug Market Size by Application
        10.2.1 Middle East and Africa Chagas Disease Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Chagas Disease Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Chagas Disease Drug Market Size by Country
        10.3.1 Middle East and Africa Chagas Disease Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Chagas Disease Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 AstraZeneca Plc
        11.1.1 AstraZeneca Plc Corporation Information
        11.1.2 AstraZeneca Plc Overview
        11.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 AstraZeneca Plc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AstraZeneca Plc Recent Developments
    11.2 Bayer AG
        11.2.1 Bayer AG Corporation Information
        11.2.2 Bayer AG Overview
        11.2.3 Bayer AG Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer AG Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer AG Recent Developments
    11.3 Daiichi Sankyo Co Ltd
        11.3.1 Daiichi Sankyo Co Ltd Corporation Information
        11.3.2 Daiichi Sankyo Co Ltd Overview
        11.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Daiichi Sankyo Co Ltd Recent Developments
    11.4 Eisai Co Ltd
        11.4.1 Eisai Co Ltd Corporation Information
        11.4.2 Eisai Co Ltd Overview
        11.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eisai Co Ltd Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eisai Co Ltd Recent Developments
    11.5 GlaxoSmithKline Plc
        11.5.1 GlaxoSmithKline Plc Corporation Information
        11.5.2 GlaxoSmithKline Plc Overview
        11.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline Plc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline Plc Recent Developments
    11.6 Grupo Praxis Pharmaceutical SA
        11.6.1 Grupo Praxis Pharmaceutical SA Corporation Information
        11.6.2 Grupo Praxis Pharmaceutical SA Overview
        11.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Grupo Praxis Pharmaceutical SA Recent Developments
    11.7 Humanigen Inc
        11.7.1 Humanigen Inc Corporation Information
        11.7.2 Humanigen Inc Overview
        11.7.3 Humanigen Inc Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Humanigen Inc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Humanigen Inc Recent Developments
    11.8 Kancera AB
        11.8.1 Kancera AB Corporation Information
        11.8.2 Kancera AB Overview
        11.8.3 Kancera AB Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Kancera AB Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Kancera AB Recent Developments
    11.9 Merck & Co Inc
        11.9.1 Merck & Co Inc Corporation Information
        11.9.2 Merck & Co Inc Overview
        11.9.3 Merck & Co Inc Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Merck & Co Inc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Merck & Co Inc Recent Developments
    11.10 Novartis AG
        11.10.1 Novartis AG Corporation Information
        11.10.2 Novartis AG Overview
        11.10.3 Novartis AG Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Novartis AG Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Novartis AG Recent Developments
    11.11 Oblita Therapeutics BVBA
        11.11.1 Oblita Therapeutics BVBA Corporation Information
        11.11.2 Oblita Therapeutics BVBA Overview
        11.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Oblita Therapeutics BVBA Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Oblita Therapeutics BVBA Recent Developments
    11.12 Sanofi
        11.12.1 Sanofi Corporation Information
        11.12.2 Sanofi Overview
        11.12.3 Sanofi Chagas Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Sanofi Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Chagas Disease Drug Industry Chain Analysis
    12.2 Chagas Disease Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Chagas Disease Drug Production Mode & Process
    12.4 Chagas Disease Drug Sales and Marketing
        12.4.1 Chagas Disease Drug Sales Channels
        12.4.2 Chagas Disease Drug Distributors
    12.5 Chagas Disease Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Chagas Disease Drug Industry Trends
    13.2 Chagas Disease Drug Market Drivers
    13.3 Chagas Disease Drug Market Challenges
    13.4 Chagas Disease Drug Market Restraints
14 Key Findings in The Global Chagas Disease Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Chagas Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Cz-007
    Table 3. Major Manufacturers of Cz-008
    Table 4. Major Manufacturers of D-121
    Table 5. Major Manufacturers of DNDI-0690
    Table 6. Major Manufacturers of EPLBS-1246
    Table 7. Major Manufacturers of EPLBS-967
    Table 8. Major Manufacturers of Others
    Table 9. Global Chagas Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Chagas Disease Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Chagas Disease Drug Sales by Region (2017-2022) & (K Pcs)
    Table 12. Global Chagas Disease Drug Sales Market Share by Region (2017-2022)
    Table 13. Global Chagas Disease Drug Sales by Region (2023-2028) & (K Pcs)
    Table 14. Global Chagas Disease Drug Sales Market Share by Region (2023-2028)
    Table 15. Global Chagas Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Chagas Disease Drug Revenue Market Share by Region (2017-2022)
    Table 17. Global Chagas Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Chagas Disease Drug Revenue Market Share by Region (2023-2028)
    Table 19. Global Chagas Disease Drug Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 20. Global Chagas Disease Drug Sales Share by Manufacturers (2017-2022)
    Table 21. Global Chagas Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Chagas Disease Drug Revenue Share by Manufacturers (2017-2022)
    Table 23. Chagas Disease Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 24. Global Chagas Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chagas Disease Drug as of 2021)
    Table 26. Chagas Disease Drug Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Chagas Disease Drug Product Offered
    Table 28. Date of Manufacturers Enter into Chagas Disease Drug Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 31. Global Chagas Disease Drug Sales by Type (2023-2028) & (K Pcs)
    Table 32. Global Chagas Disease Drug Sales Share by Type (2017-2022)
    Table 33. Global Chagas Disease Drug Sales Share by Type (2023-2028)
    Table 34. Global Chagas Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Chagas Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Chagas Disease Drug Revenue Share by Type (2017-2022)
    Table 37. Global Chagas Disease Drug Revenue Share by Type (2023-2028)
    Table 38. Chagas Disease Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 39. Global Chagas Disease Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 40. Global Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
    Table 41. Global Chagas Disease Drug Sales by Application (2023-2028) & (K Pcs)
    Table 42. Global Chagas Disease Drug Sales Share by Application (2017-2022)
    Table 43. Global Chagas Disease Drug Sales Share by Application (2023-2028)
    Table 44. Global Chagas Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Chagas Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Chagas Disease Drug Revenue Share by Application (2017-2022)
    Table 47. Global Chagas Disease Drug Revenue Share by Application (2023-2028)
    Table 48. Chagas Disease Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Global Chagas Disease Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 50. North America Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 51. North America Chagas Disease Drug Sales by Type (2023-2028) & (K Pcs)
    Table 52. North America Chagas Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Chagas Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
    Table 55. North America Chagas Disease Drug Sales by Application (2023-2028) & (K Pcs)
    Table 56. North America Chagas Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Chagas Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 59. North America Chagas Disease Drug Sales by Country (2023-2028) & (K Pcs)
    Table 60. North America Chagas Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Chagas Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 63. Europe Chagas Disease Drug Sales by Type (2023-2028) & (K Pcs)
    Table 64. Europe Chagas Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Chagas Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
    Table 67. Europe Chagas Disease Drug Sales by Application (2023-2028) & (K Pcs)
    Table 68. Europe Chagas Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Chagas Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 71. Europe Chagas Disease Drug Sales by Country (2023-2028) & (K Pcs)
    Table 72. Europe Chagas Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Chagas Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 75. Asia Pacific Chagas Disease Drug Sales by Type (2023-2028) & (K Pcs)
    Table 76. Asia Pacific Chagas Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Chagas Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
    Table 79. Asia Pacific Chagas Disease Drug Sales by Application (2023-2028) & (K Pcs)
    Table 80. Asia Pacific Chagas Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Chagas Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Chagas Disease Drug Sales by Region (2017-2022) & (K Pcs)
    Table 83. Asia Pacific Chagas Disease Drug Sales by Region (2023-2028) & (K Pcs)
    Table 84. Asia Pacific Chagas Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Chagas Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 87. Latin America Chagas Disease Drug Sales by Type (2023-2028) & (K Pcs)
    Table 88. Latin America Chagas Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Chagas Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
    Table 91. Latin America Chagas Disease Drug Sales by Application (2023-2028) & (K Pcs)
    Table 92. Latin America Chagas Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Chagas Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 95. Latin America Chagas Disease Drug Sales by Country (2023-2028) & (K Pcs)
    Table 96. Latin America Chagas Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Chagas Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 99. Middle East and Africa Chagas Disease Drug Sales by Type (2023-2028) & (K Pcs)
    Table 100. Middle East and Africa Chagas Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Chagas Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
    Table 103. Middle East and Africa Chagas Disease Drug Sales by Application (2023-2028) & (K Pcs)
    Table 104. Middle East and Africa Chagas Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Chagas Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 107. Middle East and Africa Chagas Disease Drug Sales by Country (2023-2028) & (K Pcs)
    Table 108. Middle East and Africa Chagas Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Chagas Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 110. AstraZeneca Plc Corporation Information
    Table 111. AstraZeneca Plc Description and Major Businesses
    Table 112. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 113. AstraZeneca Plc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. AstraZeneca Plc Recent Developments
    Table 115. Bayer AG Corporation Information
    Table 116. Bayer AG Description and Major Businesses
    Table 117. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 118. Bayer AG Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bayer AG Recent Developments
    Table 120. Daiichi Sankyo Co Ltd Corporation Information
    Table 121. Daiichi Sankyo Co Ltd Description and Major Businesses
    Table 122. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 123. Daiichi Sankyo Co Ltd Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Daiichi Sankyo Co Ltd Recent Developments
    Table 125. Eisai Co Ltd Corporation Information
    Table 126. Eisai Co Ltd Description and Major Businesses
    Table 127. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 128. Eisai Co Ltd Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Eisai Co Ltd Recent Developments
    Table 130. GlaxoSmithKline Plc Corporation Information
    Table 131. GlaxoSmithKline Plc Description and Major Businesses
    Table 132. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 133. GlaxoSmithKline Plc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. GlaxoSmithKline Plc Recent Developments
    Table 135. Grupo Praxis Pharmaceutical SA Corporation Information
    Table 136. Grupo Praxis Pharmaceutical SA Description and Major Businesses
    Table 137. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 138. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Grupo Praxis Pharmaceutical SA Recent Developments
    Table 140. Humanigen Inc Corporation Information
    Table 141. Humanigen Inc Description and Major Businesses
    Table 142. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 143. Humanigen Inc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Humanigen Inc Recent Developments
    Table 145. Kancera AB Corporation Information
    Table 146. Kancera AB Description and Major Businesses
    Table 147. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 148. Kancera AB Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Kancera AB Recent Developments
    Table 150. Merck & Co Inc Corporation Information
    Table 151. Merck & Co Inc Description and Major Businesses
    Table 152. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 153. Merck & Co Inc Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Merck & Co Inc Recent Developments
    Table 155. Novartis AG Corporation Information
    Table 156. Novartis AG Description and Major Businesses
    Table 157. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 158. Novartis AG Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Novartis AG Recent Developments
    Table 160. Oblita Therapeutics BVBA Corporation Information
    Table 161. Oblita Therapeutics BVBA Description and Major Businesses
    Table 162. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 163. Oblita Therapeutics BVBA Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Oblita Therapeutics BVBA Recent Developments
    Table 165. Sanofi Corporation Information
    Table 166. Sanofi Description and Major Businesses
    Table 167. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 168. Sanofi Chagas Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Sanofi Recent Developments
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Chagas Disease Drug Distributors List
    Table 173. Chagas Disease Drug Customers List
    Table 174. Chagas Disease Drug Market Trends
    Table 175. Chagas Disease Drug Market Drivers
    Table 176. Chagas Disease Drug Market Challenges
    Table 177. Chagas Disease Drug Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chagas Disease Drug Product Picture
    Figure 3. Global Chagas Disease Drug Market Share by Type in 2021 & 2028
    Figure 3. Cz-007 Product Picture
    Figure 4. Cz-008 Product Picture
    Figure 5. D-121 Product Picture
    Figure 6. DNDI-0690 Product Picture
    Figure 7. EPLBS-1246 Product Picture
    Figure 8. EPLBS-967 Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Chagas Disease Drug Market Share by Application in 2021 & 2028
    Figure 11. Hospital
    Figure 12. Clinic
    Figure 13. Others
    Figure 14. Chagas Disease Drug Report Years Considered
    Figure 15. Global Chagas Disease Drug Sales 2017-2028 (K Pcs)
    Figure 16. Global Chagas Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Chagas Disease Drug Revenue 2017-2028 (US$ Million)
    Figure 18. Global Chagas Disease Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Chagas Disease Drug Sales Market Share by Region (2017-2022)
    Figure 20. Global Chagas Disease Drug Sales Market Share by Region (2023-2028)
    Figure 21. North America Chagas Disease Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 22. North America Chagas Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Chagas Disease Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Europe Chagas Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Chagas Disease Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Asia-Pacific Chagas Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Chagas Disease Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Latin America Chagas Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Chagas Disease Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 30. Middle East & Africa Chagas Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Chagas Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Chagas Disease Drug in the World: Market Share by Chagas Disease Drug Revenue in 2021
    Figure 33. Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Chagas Disease Drug Sales Market Share by Type (2017-2028)
    Figure 35. Global Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 36. Global Chagas Disease Drug Sales Market Share by Application (2017-2028)
    Figure 37. Global Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Chagas Disease Drug Sales Market Share by Type (2017-2028)
    Figure 39. North America Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 40. North America Chagas Disease Drug Sales Market Share by Application (2017-2028)
    Figure 41. North America Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 42. North America Chagas Disease Drug Sales Share by Country (2017-2028)
    Figure 43. North America Chagas Disease Drug Revenue Share by Country (2017-2028)
    Figure 44. U.S. Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Chagas Disease Drug Sales Market Share by Type (2017-2028)
    Figure 47. Europe Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Chagas Disease Drug Sales Market Share by Application (2017-2028)
    Figure 49. Europe Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Chagas Disease Drug Sales Share by Country (2017-2028)
    Figure 51. Europe Chagas Disease Drug Revenue Share by Country (2017-2028)
    Figure 52. Germany Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. France Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Chagas Disease Drug Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Chagas Disease Drug Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Chagas Disease Drug Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Chagas Disease Drug Revenue Share by Region (2017-2028)
    Figure 63. China Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. India Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Chagas Disease Drug Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Chagas Disease Drug Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Chagas Disease Drug Sales Share by Country (2017-2028)
    Figure 78. Latin America Chagas Disease Drug Revenue Share by Country (2017-2028)
    Figure 79. Mexico Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Chagas Disease Drug Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Chagas Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Chagas Disease Drug Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Chagas Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Chagas Disease Drug Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Chagas Disease Drug Revenue Share by Country (2017-2028)
    Figure 88. Turkey Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Chagas Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 91. Chagas Disease Drug Value Chain
    Figure 92. Chagas Disease Drug Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca Plc
Bayer AG
Daiichi Sankyo Co Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
Grupo Praxis Pharmaceutical SA
Humanigen Inc
Kancera AB
Merck & Co Inc
Novartis AG
Oblita Therapeutics BVBA
Sanofi
Frequently Asked Questions
Chagas Disease Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chagas Disease Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chagas Disease Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Natural Lutein

Natural Lutein market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More